General

A thorough review raises questions about the effectiveness and safety of drugs targeting amyloid proteins in Alzheimer’s treatment.

Tarlatamab is emerging as a promising option for improving survival rates in patients with difficult-to-treat small-cell lung cancer.

A recent study explores the obstacles faced by patients and caregivers in the Canadian healthcare system.

A large-scale study offers a detailed view of hippocampal changes from youth to old age.

Alzheimer’s disease pathology can influence the effectiveness of shunt procedures in patients with idiopathic normal pressure hydrocephalus.

New research highlights the potential of astrocytes in reducing Alzheimer’s-related brain plaques.

Advancements in diagnostics and treatment have reshaped our understanding of autoimmune myelitis in oncology.

New research sheds light on the unfolding and refolding of prion proteins, offering clues to the mechanisms behind prion propagation.

Research indicates that brain hyperperfusion may influence motor dysfunction in Parkinson’s patients, independently of dopamine depletion.

Mouse studies suggest ononin might boost cognitive function by improving neuronal activity and blood flow.